Dan Zou
Kaili, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
FN-1501 Synergistically Enhances Almonertinib Efficacy in EGFR-TKI-Resistant Lung Adenocarcinoma through Ferroptosis Induction.
Journal: Anti-cancer agents in medicinal chemistry
Published: September 07, 2025
Development and validation of an interpretable machine learning model for predicting progression-free survival after immunotherapy in patients with non-small cell lung cancer: a multicenter study.
Journal: Frontiers in immunology
Published: August 15, 2025
The EP300-Targeting Drug CCS1477 Inhibits the Growth and Development of Diffuse Large B-Cell Lymphoma by Promoting Apoptosis and Mitophagy to Reduce Drug Resistance.
Journal: Anti-cancer agents in medicinal chemistry
Published: July 28, 2025
Development and validation of a circulating tumor DNA-based machine learning model for predicting immunotherapy response in non-small cell lung cancer.
Journal: Translational cancer research
Published: June 04, 2025
A novel radiomics model combining GTVp, GTVnd, and clinical data for chemoradiotherapy response prediction in patients with advanced NSCLC.
Journal: Frontiers in medicine
Published: March 20, 2025
Identification and validation of crotonylation-related diagnostic markers for lung adenocarcinoma via weighted correlation network analysis and machine learning.
Journal: Translational lung cancer research
Published: February 25, 2025
Efficacy of rechallenge after first-line immunotherapy for advanced gastric cancer: A retrospective real-world study.
Journal: Human vaccines & immunotherapeutics
Published: November 04, 2024
FN-1501 Inhibits Diffuse Large B-Cell Lymphoma Tumor Growth by Inducing Cell Cycle Arrest and Apoptosis.
Journal: Anti-cancer agents in medicinal chemistry
Published: July 27, 2024
Bromodomain proteins as potential therapeutic targets for B-cell non-Hodgkin lymphoma.
Journal: Cell & bioscience
Published: June 26, 2024
A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma.
Journal: Journal of translational medicine
Published: November 01, 2023
Deep learning to estimate durable clinical benefit and prognosis from patients with non-small cell lung cancer treated with PD-1/PD-L1 blockade.
Journal: Frontiers in immunology
Published: June 03, 2022
A Somatic Mutation Signature Predicts the Best Overall Response to Anti-programmed Cell Death Protein-1 Treatment in Epidermal Growth Factor Receptor/Anaplastic Lymphoma Kinase-Negative Non-squamous Non-small Cell Lung Cancer.
Journal: Frontiers in medicine
Published: November 03, 2021
Last Updated: 09/26/2026